Tropicamide Related Published Studies
Well-designed clinical trials related to Tropicamide (Tropicamide Ophthalmic)
A double-blind, placebo-controlled, randomized, crossover pilot study of the
safety and efficacy of multiple doses of intra-oral tropicamide films for the
short-term relief of sialorrhea symptoms in Parkinson's disease patients. [2011]
Effective pupil dilatation with a mixture of 0.75% tropicamide and 2.5% phenylephrine: A randomized controlled trial. [2009.09]
Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%. [2009]
Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation. [2006.11]
The mydriatic effect of multiple doses of tropicamide. [2005.11]
Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients. [2005.04]
A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents. [2004.05]
Randomized clinical trial of the efficacy and safety of tropicamide and phenylephrine in preoperative mydriasis for phacoemulsification. [2003.02]
Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment. [2003.01]
Effects of topical 0.5% tropicamide on intraocular pressure in normal cats. [2002.06]
Tropicamide (1%): an effective cycloplegic agent for myopic children. [2001.07]
Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. [2001.06]
Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. [2001.04]
Comparison of mydriatic efficacy of spray application and drop instillation of tropicamide 1%. [1999.10]
Effect of proparacaine on tropicamide-induced mydriasis. [1997.12]
Comparison of efficacy and tolerance between 1% hydroxyamphetamine plus 0.25% tropicamide (Paremyd) and 0.5% tropicamide combined with 2.5% phenylephrine. [1996.11]
Pupillary response to tropicamide in patients with Alzheimer disease. [1996.03]
Reversal of tropicamide mydriasis with single instillations of pilocarpine can induce substantial pseudo-myopia in young adults. [1995.09]
A pre-operative mydriatic regime using a single application of tropicamide Novel Ophthalmic Delivery System and guttae phenylephrine 10%. [1995]
Dapiprazole clinical efficiency for counteracting tropicamide 1%. [1994.05]
Comparison of cyclopentolate versus tropicamide cycloplegia in children. [1993.12]
The effect of dapiprazole on accommodative amplitude in eyes dilated with 0.5 percent tropicamide. [1993.09]
Effects of pilocarpine and tropicamide on blood-aqueous barrier permeability in man. [1992.02]
Ideal concentration of tropicamide with hydroxyamphetamine 1% for routine pupillary dilation. [1989.09]
A pupillographic evaluation of a phenylephrine HCl 5%-tropicamide 0.8% combination mydriatic. [1989.09]
Influence of thymoxamine eye-drops on the mydriatic effect of tropicamide and phenylephrine alone and in combination. [1989.04]
Reversal of tropicamide-induced mydriasis by thymoxamine eye drops. [1988]
Well-designed clinical trials possibly related to Tropicamide (Tropicamide Ophthalmic)
Comparative study of mydriasis in cataract surgery: topical versus Mydriasert versus intracameral mydriasis in cataract surgery. [2010.11]
Evaluation of the analgesic effect of intracameral lidocaine hydrochloride injection on intraoperative and postoperative pain in healthy dogs undergoing phacoemulsification. [2010.02]
Comparison of two drug combinations for dilating dark irides. [2010.02]
Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients. [2009.11]
[Biological effect of electrical plum-blossom needle for treatment of juvenile myopia] [2007.10]
Visual acuity with spherical and toric soft contact lenses in low- to moderate-astigmatic eyes. [2007.10]
Mist delivery of eye medication to the anterior segment. [2007.07]
Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. [2007.03]
Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery. [2006.11.27]
[Efficacy and efficiency of preoperative mydriasis: drops versus ocular insert] [2006.09]
Pupil dilation using a pledget sponge: a randomized controlled trial. [2006.08]
Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye. [2006.07]
Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery. [2006.06]
Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. [2005.05]
Is measurement of blood pressure worthwhile in the diabetic eye clinic? [2005.03]
Evaluation of a new preoperative ophthalmic solution. [2005.02]
Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria. [2005.01]
Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation. [2004.11]
[The Mydriasert insert: an alternative to eye drops for preangiographic mydriasis] [2004.10]
Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. [2004.07]
[Phacoemulsification without mydriasis before surgery: benefits to the patient] [2004.02]
Effect of ibopamine on aqueous humor production in normotensive humans. [2003.11]
Driving ability after pupillary dilatation. [2003.08]
A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. [2003.04]
Interventions to retard myopia progression in children: an evidence-based update. [2002.03]
Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). [2002.02]
Seasonal variation in myopia progression and ocular elongation. [2002.01]
Probing peripheral and central cholinergic system responses. [2000.09]
Ocular gelfoam disc-applicator for pupillary dilation in humans. [2000.08]
Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. [2000.01]
Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma. [1999.04]
The clinical efficacy of paremyd with and without dapiprazole in subjects with light and dark brown irides. [1999.02]
A randomized comparison study of drop versus spray topical cycloplegic application. [1999]
Comparison of the cardiovascular effects of 2.5% phenylephrine and 10% phenylephrine during ophthalmic surgery. [1998]
Effectiveness of topical diclofenac in relieving photophobia after pupil dilation. [1997.06]
Effect of locally applied prazosin on the kinetics of the pupillary light reflex. [1996.08]
Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. [1996.05]
Effects and side effects of mydriatic eyedrops in neonates. [1996.04]
The additive miotic effects of dapiprazole and pilocarpine. [1995.07]
Effects of subconjunctival methylprednisolone on the blood aqueous barrier following cataract surgery. [1995]
The effects of phenylephrine 2.5% versus phenylephrine 10% on pupillary dilation in patients with diabetes. [1995]
Intraocular thymoxamine or acetylcholine for the reversal of mydriasis. [1994.11]
Mydriatic efficacy of a cycloplegic spray in the pediatric population. [1993.09]
Efficacy of a pediatric cycloplegic administered as a spray. [1993.09]
The effects on pupil size and accommodation of sympathetic and parasympatholytic agents. [1993.07]
Is post-cataract mydriasis necessary? [1993]
Effect of mydriasis on visual field area in retinitis pigmentosa. [1992.11]
A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. [1992.05]
Apraclonidine prophylaxis for postcycloplegic intraocular pressure spikes. [1991.07]
Reversal of mydriasis by dapiprazole. [1990.04]
Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies. [1990.02]
The ophthalmic rod: a new ophthalmic drug delivery system I. [1990]
Pupillographic evaluation of the mydriatic effect of ibopamine solution. [1989.07]
A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. [1986.11]
Other research related to Tropicamide (Tropicamide Ophthalmic)
Comparison of the effectiveness of mydriasis by two instillation methods of
combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants. [2012]
A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients. [2011.11.15]
Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats. [2011.11]
Effect of topical 1% tropicamide on Schirmer tear test results in clinically normal horses. [2009.11]
Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. [2009.09.29]
Parenteral ophthalmic tropicamide or cyclopentolate protects rats from lethal organophosphate poisoning. [2009.05]
Determination of tropicamide and its major impurity in raw material by the HPLC-DAD analysis and identification of this impurity using the off-line HPLC-FT-IR coupling. [2009.02.20]
Determination of tropicamide and its major impurity in raw material by the HPLC-DAD analysis and identification of this impurity using the off-line HPLC-FT-IR coupling. [2008.10.28]
Variation in intraocular pressure following application of tropicamide in three different dog breeds. [2007.11]
The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors. [2007.10]
Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)? [2007.05]
Cycloplegic effect of 0.5% tropicamide and 0.5% phenylephrine mixed eye drops: objective assessment in Japanese schoolchildren with myopia. [2007.03]
[The influence of phenylephrine and tropicamide on higher order monochromatic aberrations] [2007.03]
Changes in chromatic and achromatic contrast sensitivities following tropicamide administration. [2007.02]
Changes in chromatic and achromatic contrast sensitivities following tropicamide administration. [2007.02]
Other possibly related research studies
Acute angle closure after implantable contact lens insertion unresponsive to surgical peripheral iridectomy. [2008.04]
Evaluation of fungal and bacterial contaminations of patient-used ocular drops. [2008.02]
Anterior movement of the crystalline lens in the process of accommodation in children. [2007.07]
Allergic contact blepheroconjunctivitis with phenylephrine eyedrops--the relevance of late readings of intradermal tests. [2007.07]
Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis. [2007.11]
|
